- Home
- BENF vs CCEL Comparison
BENF vs CCEL Comparison
Compare BENF & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BENF | CCEL |
|---|---|---|
| Founded | 2003 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Managed Health Care |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.2M | 32.7M |
| IPO Year | 2023 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BENF | CCEL |
|---|---|---|
| Price | $1.05 | $4.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 9.4M | 10.5K |
| Earning Date | 11-13-2026 | 10-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $25,384,279.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.87 |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $0.50 | $2.72 |
| 52 Week High | $60.00 | $4.90 |
Technical Indicators
Market Signals| Indicator | BENF | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 45.39 | 51.91 |
| Support Level | $0.50 | $3.15 |
| Resistance Level | $3.81 | $4.71 |
| Average True Range (ATR) | 0.15 | 0.38 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 31.00 | 53.06 |
Price Performance
Historical ComparisonAbout BENF Beneficient
Beneficient is a technology-enabled financial services holding company providing liquidity solutions and trust products and services to participants in the alternative assets industry through an online platform, AltAccess. Its services are focused on alternative asset investors, institutional investors, family offices, and fund managers. The company provides liquidity solutions for alternative asset investments through financing and trust structures. The company has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts. The majority of revenue is derived from the Ben Liquidity segment in the form of interest income.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.